Ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) prevents cell death in a cellular model of Parkinson's disease
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 506 (3) , 516-521
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP 25860112, 17K08444)
This publication has 34 references indexed in Scilit:
- Endoplasmic Reticulum Stress and Parkinson’s Disease: The Role of HRD1 in Averting Apoptosis in Neurodegenerative DiseaseOxidative Medicine and Cellular Longevity, 2013
- SEL1L Protein Critically Determines the Stability of the HRD1-SEL1L Endoplasmic Reticulum-associated Degradation (ERAD) Complex to Optimize the Degradation Kinetics of ERAD SubstratesJournal of Biological Chemistry, 2011
- Loss of HRD1-Mediated Protein Degradation Causes Amyloid Precursor Protein Accumulation and Amyloid-β GenerationThe Journal of Neuroscience, 2010
- SEL1L and HRD1 are involved in the degradation of unassembled secretory Ig‐µ chainsJournal of Cellular Physiology, 2008
- Immunohistochemical localization of a ubiquitin ligase HRD1 in murine brainJournal of Neuroscience Research, 2008
- A different pathway in the endoplasmic reticulum stress‐induced expression of human HRD1 and SEL1 genesFEBS Letters, 2007
- SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ERJournal of Cell Biology, 2006
- ER stress and neurodegenerative diseasesCell Death & Differentiation, 2006
- Parkinsonian Mimetics Induce Aspects of Unfolded Protein Response in Death of Dopaminergic NeuronsJournal of Biological Chemistry, 2003
- Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlatesAnnals of Neurology, 1988